Microbicides
Microbicides
Coverage of HIV Research for Prevention Conference (HIVR4P 2014)
- Details
- Category: HIV Prevention
- Published on Tuesday, 04 November 2014 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the HIV Research for Prevention Conference (HIVR4P 2014), October 28-31, in Cape Town.
This conference -- combining the previous HIV Vaccines and Microbicides meetings -- includes all aspects of HIV prevention including experimental vaccines, microbicide gels and rings, and pre-exposure prophylaxis (PrEP).
Full listing of coverage by topic
11/4/14
HIVR4P 2014: Tenofovir Gel Associated with Lower Herpes Simplex Risk for Women
- Details
- Category: Microbicides
- Published on Friday, 31 October 2014 00:00
- Written by Lesley Odendal
The risk of acquiring herpes simplex virus type 2 (HSV-2) was reduced by 46% among women who regularly used a vaginal gel containing tenofovir, according to a secondary analysis of the VOICE trial presented at the HIV Research for Prevention conference (R4P) this week in Cape Town. There was no significant difference in the age, marital status, country, practice of anal sex, HIV status, or hormonal contraceptive use between women who acquired HSV-2 and those who did not.
ICAAC 2014: Tenofovir Vaginal Ring and Nanoparticle Gel Are Protective in Animal Studies
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Tuesday, 16 September 2014 00:00
- Written by Liz Highleyman
A vaginal ring that dispenses tenofovir protected all 6 macaque monkeys exposed to an HIV-like virus, while a heat-sensitive vaginal gel containing tenofovir nanoparticles prevented infection of mice, researchers reported at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy last week in Washington, DC.
HIV Research for Prevention Conference Features Advances in Vaccines, Microbicides, PrEP
- Details
- Category: HIV Prevention
- Published on Tuesday, 28 October 2014 00:00
- Written by HIV R4P
The first HIV Research for Prevention -- or HIV R4P -- conference takes place this week in Cape Town, bringing together more than 1300 leading researchers, policymakers, and advocates working on interventions such as HIV vaccines, microbicides, antiretroviral treatment as prevention (TasP), and new forms of pre-exposure prophylaxis (PrEP). The conference incorporates the previously separate HIV vaccine and microbicide meetings as biomedical prevention technologies have converged.
NIH Awards Grant for Vaginal Ring for HIV Prevention
- Details
- Category: HIV Prevention
- Published on Friday, 12 September 2014 00:00
- Written by Oak Crest Institute of Science
The National Institutes of Health has awarded a $20 million grant to a consortium that will seek to develop an intravaginal ring that delivers antiretroviral drugs for prevention of HIV infection, the participating research institutions recently announced. The collaboration will test various combinations of antiretrovirals to determine which are most effective when delivered together for pre-exposure prophylaxis, or PrEP.
More Articles...
- Dapivirine Vaginal Ring Study Fully Enrolled, New Technology Shows Promise
- Microbicide Gel Protects against Vaginal or Anal Transmission of HIV and Other STIs
- CROI 2014: Self-Reports Did Not Reflect Actual Gel or Pill Use in VOICE PrEP Trial
- CROI 2014: Dapivirine Vaginal Ring Appears Safe and Effective in Tissue Study
Web Design and Development by